Drug Combinations clinical trials
How each study uses Drug Combinations is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Drug Combinations studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
3 studies that test it; most in 2019 (1)
| Year | Studies |
|---|---|
| 2019 | 1 |
| 2021 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 3
University Hospital, Clermont-Ferrand (1) · University General Hospital of Patras (1) · Seoul National University Hospital (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Drug Combinations is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Anesthesia Techniques, Neuroprotection and Surgical Field in FESS Under Controlled HypotensionRecruitingNot applicableUniversity General Hospital of PatrasNCT07181564Written as Ketamine + Magnesium sulfate (drug combination)
- Ketamine + Magnesium for Chronic Cluster Headache (KETALGIA)CompletedPhase 4University Hospital, Clermont-FerrandNCT04814381Written as Ketamine + Magnesium sulfate (drug combination)
- Daratumumab With DCEP for Multiple Myeloma With PlasmacytomaStatus unknownPhase 2Seoul National University HospitalNCT04065308Written as Drug Combinations
Codes
What other systems call Drug Combinations · ClinicalTrials.gg INT007403
- MeSH (NLM) D004338Drug CombinationsOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D004338 | Drug Combinations | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.